• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物与单层相遇:使用分子动力学模拟了解固醇类药物与肺表面活性剂单层模型的相互作用。

Drug Meets Monolayer: Understanding the Interactions of Sterol Drugs with Models of the Lung Surfactant Monolayer Using Molecular Dynamics Simulations.

机构信息

School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia.

School of Mechanical and Mechatronic Engineering, University of Technology Sydney, Ultimo, NSW, Australia.

出版信息

Methods Mol Biol. 2022;2402:103-121. doi: 10.1007/978-1-0716-1843-1_9.

DOI:10.1007/978-1-0716-1843-1_9
PMID:34854039
Abstract

The lung surfactant monolayer (LSM) is a thin layer of lipids and proteins that forms the air/water interface of the alveoli. The primary function of the LSM is to reduce the surface tension at the air/water interface during breathing. The LSM also forms the main biological barrier for any inhaled particles, including drugs, to treat lung diseases. Elucidating the mechanism by which these drugs bind to and absorb into the LSM requires a molecular-level understanding of any drug-induced changes to the morphology, structure, and phase changes of the LSM.Molecular dynamics simulations have been used extensively to study the structure and dynamics of the LSM. The monolayer is usually simulated in at least two states: the compressed state, mimicking exhalation, and the expanded state, mimicking inhalation. In this chapter, we provide detailed instructions on how to set up, run, and analyze coarse-grained MD simulations to study the concentration-dependent effect of a sterol drug on the LSM, both in the expanded and compressed state.

摘要

肺表面活性剂单层(LSM)是一层薄薄的脂质和蛋白质,形成肺泡的气/水界面。LSM 的主要功能是在呼吸过程中降低气/水界面的表面张力。LSM 还为任何吸入的颗粒(包括药物)形成主要的生物屏障,以治疗肺部疾病。阐明这些药物与 LSM 结合并吸收进入 LSM 的机制需要对药物诱导的 LSM 形态、结构和相变化有分子水平的理解。分子动力学模拟已被广泛用于研究 LSM 的结构和动力学。单层通常模拟至少两种状态:模拟呼气的压缩状态和模拟吸气的扩展状态。在本章中,我们提供了详细的说明,介绍如何设置、运行和分析粗粒度 MD 模拟,以研究甾醇药物在扩展和压缩状态下对 LSM 的浓度依赖性影响。

相似文献

1
Drug Meets Monolayer: Understanding the Interactions of Sterol Drugs with Models of the Lung Surfactant Monolayer Using Molecular Dynamics Simulations.药物与单层相遇:使用分子动力学模拟了解固醇类药物与肺表面活性剂单层模型的相互作用。
Methods Mol Biol. 2022;2402:103-121. doi: 10.1007/978-1-0716-1843-1_9.
2
The steroid mometasone alters protein containing lung surfactant monolayers in a concentration-dependent manner.类固醇倍氯米松以浓度依赖的方式改变含有蛋白质的肺表面活性剂单层。
J Mol Graph Model. 2022 Mar;111:108084. doi: 10.1016/j.jmgm.2021.108084. Epub 2021 Nov 20.
3
Shape matters-the interaction of gold nanoparticles with model lung surfactant monolayers.形状很重要——金纳米颗粒与模型肺表面活性剂单层的相互作用。
J R Soc Interface. 2021 Oct;18(183):20210402. doi: 10.1098/rsif.2021.0402. Epub 2021 Oct 13.
4
Concentration-Dependent Effect of the Steroid Drug Prednisolone on a Lung Surfactant Monolayer.类固醇药物泼尼松龙对肺表面活性剂单层的浓度依赖性效应。
Langmuir. 2022 Apr 12;38(14):4188-4199. doi: 10.1021/acs.langmuir.1c02817. Epub 2022 Mar 28.
5
The concentration-dependent effect of hydrocortisone on the structure of model lung surfactant monolayer by using an approach.采用一种方法研究氢化可的松对模型肺表面活性剂单层结构的浓度依赖性效应。
RSC Adv. 2022 Nov 22;12(51):33313-33328. doi: 10.1039/d2ra05268g. eCollection 2022 Nov 15.
6
Molecular insights on the interference of simplified lung surfactant models by gold nanoparticle pollutants.金纳米颗粒污染物对简化肺表面活性剂模型干扰的分子见解。
Biochim Biophys Acta Biomembr. 2019 Aug 1;1861(8):1458-1467. doi: 10.1016/j.bbamem.2019.06.001. Epub 2019 Jun 10.
7
Effect of concentration of PEG coated gold nanoparticle on lung surfactant studied with coarse-grained molecular dynamics simulations.用粗粒化分子动力学模拟研究聚乙二醇包覆金纳米粒子浓度对肺表面活性剂的影响。
Biophys Chem. 2020 Nov;266:106457. doi: 10.1016/j.bpc.2020.106457. Epub 2020 Aug 26.
8
Computer simulations of lung surfactant.肺表面活性剂的计算机模拟
Biochim Biophys Acta. 2016 Oct;1858(10):2431-2440. doi: 10.1016/j.bbamem.2016.02.030. Epub 2016 Feb 27.
9
Investigation of Drug for Pulmonary Administration-Model Pulmonary Surfactant Monolayer Interactions Using Langmuir-Blodgett Monolayer and Molecular Dynamics Simulation: A Case Study of Ketoprofen.肺部给药药物研究-使用 Langmuir-Blodgett 单层膜和分子动力学模拟研究模型肺表面活性剂单层相互作用:以酮洛芬为例。
Langmuir. 2019 Oct 15;35(41):13452-13460. doi: 10.1021/acs.langmuir.9b02412. Epub 2019 Oct 3.
10
Computational Studies of Lipid-Wrapped Gold Nanoparticle Transport Through Model Lung Surfactant Monolayers.脂质包裹的金纳米颗粒通过模型肺表面活性剂单层的传输的计算研究。
J Phys Chem B. 2021 Feb 11;125(5):1392-1401. doi: 10.1021/acs.jpcb.0c09518. Epub 2021 Feb 2.

引用本文的文献

1
and studies of the interaction between glucocorticoid drug mometasone furoate and model lung surfactant monolayer.以及糠酸莫米松糖皮质激素药物与模型肺表面活性剂单层之间相互作用的研究。
RSC Adv. 2025 Feb 26;15(8):5951-5964. doi: 10.1039/d5ra00004a. eCollection 2025 Feb 19.
2
The concentration-dependent effect of hydrocortisone on the structure of model lung surfactant monolayer by using an approach.采用一种方法研究氢化可的松对模型肺表面活性剂单层结构的浓度依赖性效应。
RSC Adv. 2022 Nov 22;12(51):33313-33328. doi: 10.1039/d2ra05268g. eCollection 2022 Nov 15.

本文引用的文献

1
The role of SP-B peptides in lung surfactant monolayers exposed to gold nanoparticles.SP-B 肽在暴露于金纳米粒子的肺表面活性剂单层中的作用。
Phys Chem Chem Phys. 2020 Jul 21;22(27):15231-15241. doi: 10.1039/d0cp00268b. Epub 2020 Jul 1.
2
Molecular insights on the interference of simplified lung surfactant models by gold nanoparticle pollutants.金纳米颗粒污染物对简化肺表面活性剂模型干扰的分子见解。
Biochim Biophys Acta Biomembr. 2019 Aug 1;1861(8):1458-1467. doi: 10.1016/j.bbamem.2019.06.001. Epub 2019 Jun 10.
3
On the Calculation of Acyl Chain Order Parameters from Lipid Simulations.
从脂质模拟计算酰基链序参数。
J Chem Theory Comput. 2017 Nov 14;13(11):5683-5696. doi: 10.1021/acs.jctc.7b00643. Epub 2017 Oct 16.
4
Computational Lipidomics with insane: A Versatile Tool for Generating Custom Membranes for Molecular Simulations.使用insane进行计算脂质组学:一种用于为分子模拟生成定制膜的通用工具。
J Chem Theory Comput. 2015 May 12;11(5):2144-55. doi: 10.1021/acs.jctc.5b00209. Epub 2015 Apr 24.
5
Barrier or carrier? Pulmonary surfactant and drug delivery.屏障还是载体?肺表面活性剂与药物递送。
Eur J Pharm Biopharm. 2015 Sep;95(Pt A):117-27. doi: 10.1016/j.ejpb.2015.02.014. Epub 2015 Feb 20.
6
Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films.组成、结构和机械性能决定了肺表面活性物质膜和片的性能。
Chem Phys Lipids. 2015 Jan;185:153-75. doi: 10.1016/j.chemphyslip.2014.09.002. Epub 2014 Sep 28.
7
Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challenges.肺部药物传递:从气溶胶生成到克服生物屏障——治疗的可能性和技术挑战。
Lancet Respir Med. 2013 Jul;1(5):402-13. doi: 10.1016/S2213-2600(13)70072-9. Epub 2013 Jun 4.
8
Molecular view of phase coexistence in lipid monolayers.脂质单层中相共存的分子观点。
J Am Chem Soc. 2012 Oct 24;134(42):17543-53. doi: 10.1021/ja304792p. Epub 2012 Oct 12.
9
Lung surfactant protein SP-B promotes formation of bilayer reservoirs from monolayer and lipid transfer between the interface and subphase.肺表面活性蛋白 SP-B 促进从单层到双层储库的形成以及界面与亚相之间的脂质传递。
Biophys J. 2011 Apr 6;100(7):1678-87. doi: 10.1016/j.bpj.2011.02.019.
10
Molecular dynamics simulations of liquid condensed to liquid expanded transitions in DPPC monolayers.DPPC 单分子层中液体凝聚到液体膨胀转变的分子动力学模拟。
J Phys Chem B. 2010 Jan 28;114(3):1325-35. doi: 10.1021/jp9061303.